ERKNet

The European Rare Kidney Disease Reference Network

  

Journal Watch

Immune glomerulopathies

Prognosis and acute complications at the first onset of idiopathic nephrotic syndrome in children: a nationwide survey in Japan (JP-SHINE study).
Author(s): Sato M, Ishikura K, Ando T, Kikunaga K, Terano C, Hamada R, Ishimori S, Hamasaki Y, Araki Y, Gotoh Y, Nakanishi K, Nakazato H, Matsuyama T, Iijima K, Yoshikawa N, Ito S, Honda M
Source: Nephrol Dial Transplant 2019 Sep 24;
Publication date: 2019-09-24
Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis.
Author(s): Yi J, He Z, Xu S, Feng S
Source: Int Urol Nephrol 2019 Sep 12;
Publication date: 2019-09-12
Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome.
Author(s): Delbet JD, Aoun B, Buob D, Degheili J, Brocheriou I, Ulinski T
Source: Pediatr Nephrol 2019 Sep 13;
Publication date: 2019-09-13
CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood.
Author(s): Eroglu FK, Orhan D, İnözü M, Duzova A, Gulhan B, Ozaltin F, Topaloglu R
Source: Pediatr Int 2019 Sep 12;
Publication date: 2019-09-12
Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Author(s): Zheng Q, Yang H, Liu W, Sun W, Zhao Q, Zhang X, Jin H, Sun L
Source: BMJ Open 2019 Sep 11;9(9):e030919
Publication date: 2019-09-11
+ Show 214 more...

European Reference Networks
ERKNet is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit http://ec.europa.eu/health/ern